Dexcom | DXCM - Debt

Stock Price
61.40
Daily Change
-0.17 -0.28%
Monthly
-0.81%
Yearly
-13.74%
Q2 Forecast
60.25

Dexcom reported $1.24B in Debt for its fiscal quarter ending in December of 2025.





Debt Change Date
Abbott USD 13.86B 919M Dec/2025
Align Technology USD 121.27M 1.75M Sep/2025
AtriCure USD 76.73M 521K Sep/2025
Avanos Medical USD 133.7M 3.6M Sep/2025
Baxter International USD 9.71B 13M Sep/2025
Becton, Dickinson and Co. USD 19.54B 358M Dec/2025
Boston Scientific USD 11.44B 610M Dec/2025
Cooper Companies USD 2.51B 27M Sep/2025
Dexcom USD 1.24B 1.21B Dec/2025
Edwards Lifesciences USD 600M 105.4M Mar/2026
Globus Medical USD 119.34M 1.76M Sep/2025
Inogen USD 0 0 Jun/2022
Insulet USD 1.01B 384.9M Sep/2025
Integra LifeSciences USD 2.01B 7.91M Sep/2025
J&J USD 47.93B 2.14B Dec/2025
Masimo USD 586.2M 56M Sep/2025
Medtronic USD 28.07B 1.03B Dec/2025
Merit Medical Systems USD 821.15M 599K Sep/2025
Roche Holding CHF 33.03B 1.41B Jun/2025
Solventum Corp USD 7.91B 97M Mar/2025
Stryker USD 14.86B 1.74B Dec/2025
Tandem Diabetes Care USD 449.28M 276K Sep/2025
Teleflex USD 2.77B 774M Sep/2025
West Pharmaceutical Services USD 202.8M 0 Mar/2026
Zimmer Biomet Holdings USD 7.52B 593.5M Dec/2025